Nexgel (NXGL) Stock Price

Nexgel Price

NASDAQ·CLOSED
3.80
​
Market closed

Revenue has compounded at 20.4% per year over the past 9 years to 11.42 M USD. Nexgel's net margin stands at -26.3%, up from -277.9% several years earlier. Analysts set a median price target of 6.12 USD, implying 61.1% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Nexgel stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nexgel business model & stock analysis

NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania. The company went IPO on 2021-12-22. The firm is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its gels and its consumer products are manufactured using proprietary and non-proprietary mixing, coating, and crosslinking technologies. Its hydrogels are marketed in the United States and abroad by its customers. The firm markets under the brand names MedaGel and LumaGel Beauty. The products it sells under its MedaGel brand primarily relate to over the counter (OTC) remedy solutions, such as blister and pain applications; while the products it sells under its LumaGel Beauty brand primarily relate to beauty and cosmetic solutions, such as wrinkle and skin cream applications.

Frequently asked questions about Nexgel

Analysts currently set an average price target of 6.12 USD for the Nexgel stock (median: 6.12 USD), implying +61.1 % versus the latest price. The consensus is based on 7 analyst ratings.

6 analysts currently rate the Nexgel stock: 0 recommend buying, 3 holding and 3 selling. For 2026, analysts expect Nexgel to generate revenue of 15.79 M USD and earnings per share of -0.97 USD.

Converted at the current exchange rate, the Nexgel share trades at 3.40 EUR (3.80 USD).

The Nexgel share (NXGL) is listed on 1 stock exchanges, including: NASDAQ (NXGL).

The expected revenue of Nexgel is 15.79 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Nexgel is -7.65 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Nexgel is currently -3.90. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Nexgel stock.

The price-to-sales ratio (P/S) of Nexgel is currently 1.89. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Nexgel stock.

The Eulerpool Quality Score for Nexgel is 4/10.

The ISIN of Nexgel is US65344E1073. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Nexgel is NXGL. The ticker symbol is used to trade Nexgel shares on the stock exchange.

Fair ValueTerminal
3.65 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
1.14 M USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website nexgel.com
Currency
USD
Initial public offering
Dec 22, 2021
ISIN
US65344E1073
Cusip
65344E107
Market capitalization
30.93 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-3.90
P/Ee 2027
-16.67
P/Ee 2028
-73.33
P/Ee 2029
10.86
P/Ee 2030
190.00
P/S
P/Se
1.89
EV/EBIT
—
P/B Ratio
6.94
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-39.75 %
Last updated Nov 1, 2026, 11:13 PM

Nexgel Peer Group

Nexgel Ticker

NASDAQ · NXGL

Nexgel FIGI

NXGL:US · BBG00SK5G0B4NXGL:UA · BBG0142NJYQ4NXGL:UC · BBG0142NJYR3NXGL:UN · BBG0142NJYT1NXGL:UP · BBG0142NJYV8NXGL:UB · BBG0142NJYX6NXGL:UM · BBG0142NJYZ4NXGL:UX · BBG0142NJZ09NXGL:UR · BBG0142NJZ18NXGL:UD · BBG0142NJZ54NXGL:UF · BBG0142NJZ81NXGL:VY · BBG0142NJZ90

All fundamentals and in-depth analysis of Nexgel

Our stock analysis for Nexgel stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nexgel. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.